Abstract
The effects were assessed of Δ'THC (the psychoactive component of cannabis) and CBD and DMHP-CBD (the non-psychomimetic components of marijuana derivatives) on 14C labelled serotonin release from normal platelets, when incubated with patient's plasma obtained during migraine attack. A statistically significant inhibitory effect (p > 0.005) of 14C serotonin release was found at 10-5M, 10-6M, 10-7M Δ'THC concentrations. Plasma of migraine patients obtained in attack-free periods revealed no significant inhibitory effect on 14C serotonin release from normal platelets using the same Δ'THC concentration. CBD and DMHP-CBD had no significant inhibitory effect on 14C serotonin release from normal platelets when tested either at migraine-free period plasma or plasma obtained during migraine attack.
Original language | English |
---|---|
Pages (from-to) | 243-246 |
Number of pages | 4 |
Journal | International Journal of Clinical Pharmacology Research |
Volume | 5 |
Issue number | 4 |
State | Published - 1 Dec 1985 |
ASJC Scopus subject areas
- General Pharmacology, Toxicology and Pharmaceutics
- Pharmacology (medical)